Methicillin resistance in Staphylococcus aureus
Staphylococcus aureus is renowned for countering almost any antibiotic challenge. Its history since the advent of penicillin is one of increasing resistance to antibiotics. Methicillin was the first semisynthetic penicillin resistant to penicillinase to be derived from the penicillin nucleus and was a major advance in the treatment of staphylococcal infections. Because of its toxicity and ineffectiveness if given orally it was gradually superseded by newer penicillinase resistant penicillins such as flucloxacillin. However, methicillin is still used for susceptibility testing of staphylococci in the laboratory and so methicillin resistance is an indicator of flucloxacillin resistance. Staphylococcal resistance to methicillin is not due to the destruction of the antibiotic by a bacterial enzyme such as P-lactamase but is related to decreased affinity of the organism's penicillin binding proteins for methicillin and also the synthesis of an extra penicillin binding protein with very low affinity for P-lactam antibiotics.
Methicillin resistance in staphylococci was reported in 1961, soon after the introduction of methicillin, and naturally occurring strains may have been around before the advent of methicillin.'-3 There was a gradual increase in methicillin resistance in England throughout the 1960s, but during the 1970s attention was focused on the Gram negative bacteria, with some complacency about Gram positive bacteria.
Various epidemic strains of methicillin resistant S aureus (EMRSA) appeared in the 1980s. 4 The first of these, EMRSA-1, bore many resemblances to a strain that caused large outbreaks in hospitals in eastern Australia in the late 1970s.' It probably first appeared in England in 1980-1 and went on to cause majo-r endemic and epidemic problems. These Other places in England and abroad have had similar experiences. In the Royal London Hospital's EMRSA-1 outbreak severe infections (septicaemia, endocarditis, meningitis) were notable in the early days, before full containment measures were instituted.6 In this outbreak there were also two instances where EMRSA-1 was reponsible for a toxic shock-like illness; this was probably associated with enterotoxin production as toxic shock syndrome toxin-i was not isolated from these strains. '5 The transmission and acquisition of methicillin resistant S aureus is a multifactorial process depending not only on organism factors but also on host factors such as abnormal or damaged skin, length of hospital stay, previous antibiotic treatment, and probably the use of topical antimicrobial agents. There also seems to be genetic predisposition to carriage of S aureus, or lack of it. Not surprisingly, the hospital areas mainly affected are the intensive care, bums, dermatology, and surgical units.
Diagnosis
It is not possible to diagnose methicillin resistant S aureus infection from the patient's clinical condition as there is no characteristic clinical picture that differentiates this from other staphylococcal infections. Diagnosis of infection or colonisation will depend on the submission of appropriate specimens to the microbiology laboratory. When infection is suspected these should be from the site or sites of infection, whereas screening for colonisation (box 2) should include samples from the nose, throat, wounds, other skin lesions, insertion sites of intravascular lines, tracheostomies, catheter urine samples, perineum, and sputum. The usual strictures apply: samples should always be fresh; actual pus is better than a wound swab; and swabs in transport medium are better than dry swabs. Experience with some strains of methicillin resistant S aureus, including EMRSA-1, shows that isolation or cohort wards may be necessary.6 Surveillance of high risk admissions, screening of wards with affected patients, the tagging of affected patients' records, and the restriction of staff and patient movement within and between hospitals are also important aspects of control and are detailed in the revised guidelines for the control of epidemic methicillin resistant S aureus. 29 In some instances such as an endemic problem in a less critical area of the hospital, eradication of the methicillin resistant strain may prove impossible, requiring an acceptance of living with it. Control here may mean limiting spread outside that area.
The future
As yet little is known about the factors that make a particular strain of methicillin resistant S aureus virulent or capable of spread. The rapid identification of epidemic strains and the factors responsible for spread and colonisation would permit a more targeted approach and save on containment measures. Other areas warranting further research include the development of new topical and systemic agents, more rapid and sensitive methods of detecting colonisation, and improved typing methods.
An outbreak of methicillin resistant S aureus is costly business (box 8). It is generally agreed that the costs of ignoring EMRSA are higher than those associated with its control, particularly when the costs of potential legal action are taken into account. The average cost of treating a bacteraemia with methicillin BMJ VOLUME 307 23 OCTOBER 1993
Box 6-Clearance ofMRSA 1) . He had good biventricular function, normal valvular structure and function, but a large pericardial effusion (fig 2) . Pericardiocentesis yielded 1-5 litres of uniformly blood stained fluid. The fluid contained an exudate with a protein concentration of 540 g/l, glucose concentration of 1 9 mmol/l (serum glucose 5 mmol/l), and numerous lymphocytes. A Mantoux test was performed and gave positive results at a dilution of 1 in 10000. Computed tomography showed evidence of para-aortic and paracolic lymphadenopathy. On the basis of fever, lymphadenopathy, and the large pericardial effusion he was started on
